OATP1B1 polymorphisms and torsemide pharmacokinetics and pharmacodynamics

被引：0
|
作者：
Vormfelde, S. V. [1 ]
Toliat, M. R. [2 ]
Schirmer, M. [1 ]
Meineke, I. [1 ]
Nuernberg, P. [2 ]
Brockmoeller, J. [1 ]
机构：
[1] Univ Gottingen, Dept Clin Pharmacol, Gottingen, Germany
[2] Univ Cologne, Cologne Ctr Genom, Cologne, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2007年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [31] Rifampicin Transport by OATP1B1 Variants
    Litjens, Carlijn H. C.
    van den Heuvel, Jeroen J. M. W.
    Russel, Frans G. M.
    Aarnoutse, Rob E.
    te Brake, Lindsey H. M.
    Koenderink, Jan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (10)
  • [32] Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3
    Katuwal, Miki
    Schnegelberger, Regina
    Wityk, Elliott
    Ruggiero, Melissa
    Hagenbuch, Bruno
    FASEB JOURNAL, 2016, 30
  • [33] Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers
    Mori, Daiki
    Kashihara, Yushi
    Yoshikado, Takashi
    Kimura, Miyuki
    Hirota, Takeshi
    Matsuki, Shunji
    Maeda, Kazuya
    Irie, Shin
    Ieiri, Ichiro
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 78 - 86
  • [34] Structure of human drug transporters OATP1B1 and OATP1B3
    Anca-Denise Ciută
    Kamil Nosol
    Julia Kowal
    Somnath Mukherjee
    Ana S. Ramírez
    Bruno Stieger
    Anthony A. Kossiakoff
    Kaspar P. Locher
    Nature Communications, 14
  • [35] Structure of human drug transporters OATP1B1 and OATP1B3
    Ciuta, Anca-Denise
    Nosol, Kamil
    Kowal, Julia
    Mukherjee, Somnath
    Ramirez, Ana S.
    Stieger, Bruno
    Kossiakoff, Anthony A.
    Locher, Kaspar P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [36] Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)
    Iwai, M
    Suzuki, H
    Ieiri, I
    Otsubo, K
    Sugiyama, Y
    PHARMACOGENETICS, 2004, 14 (11): : 749 - 757
  • [37] HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
    Hartkoorn, Ruben C.
    San Kwan, Wai
    Shallcross, Victoria
    Chaikan, Ammara
    Liptrott, Neill
    Egan, Deirdre
    Sora, Enrique Salcedo
    James, Chloe E.
    Gibbons, Sara
    Bray, Pat G.
    Back, David J.
    Khoo, Saye H.
    Owen, Andrew
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (02): : 112 - 120
  • [38] The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature
    Anabtawi, Nadeen
    Drabison, Thomas
    Hu, Shuiying
    Sparreboom, Alex
    Talebi, Zahra
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (7-8) : 459 - 468
  • [39] Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
    Chen, Yu
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (02) : 147 - 154
  • [40] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
12345